Literature DB >> 22895358

Are there still healthy obese patients?

Matthias Blüher1.   

Abstract

PURPOSE OF REVIEW: Obesity is associated with an increased risk of premature death and represents a fast growing worldwide health problem that is reaching epidemic proportions. Obesity significantly increases the risk of developing metabolic disorders, hypertension, coronary heart disease, stroke, and several types of cancer. However, a subgroup of 'healthy' obese patients seems to be protected against metabolic and cardiovascular obesity comorbidities. This review focuses on potential mechanisms underlying the healthy obese subphenotype. RECENT
FINDINGS: Individuals with obesity typically develop type 2 diabetes, dyslipidemia, fatty liver disease, gout, hypertension, and cardiovascular disease. In the past years it became clear that up to 30% of obese patients are metabolically healthy with insulin sensitivity similar to healthy lean individuals, lower liver fat content, and lower intima media thickness of the carotid artery than the majority of metabolically 'unhealthy' obese patients. Recent studies suggest that protection against development of hepatic steatosis, ectopic fat deposition, inflammation of visceral adipose tissue, and adipose tissue dysfunction contributes to healthy obesity.
SUMMARY: For the stratification of obesity treatment, definition of metabolically healthy or high-risk phenotypes will facilitate the identification of the obese person who will benefit the most from early lifestyle, bariatric surgery, or pharmacological interventions.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22895358     DOI: 10.1097/MED.0b013e328357f0a3

Source DB:  PubMed          Journal:  Curr Opin Endocrinol Diabetes Obes        ISSN: 1752-296X            Impact factor:   3.243


  61 in total

Review 1.  Aldosterone Production and Signaling Dysregulation in Obesity.

Authors:  Andrea Vecchiola; Carlos F Lagos; Cristian A Carvajal; Rene Baudrand; Carlos E Fardella
Journal:  Curr Hypertens Rep       Date:  2016-03       Impact factor: 5.369

2.  A healthy lifestyle pattern is associated with a metabolically healthy phenotype in overweight and obese adults: a cross-sectional study.

Authors:  Farah Naja; Leila Itani; Mona P Nasrallah; Hassan Chami; Hani Tamim; Lara Nasreddine
Journal:  Eur J Nutr       Date:  2019-07-30       Impact factor: 5.614

Review 3.  Adipocyte dysfunction, inflammation and metabolic syndrome.

Authors:  Nora Klöting; Matthias Blüher
Journal:  Rev Endocr Metab Disord       Date:  2014-12       Impact factor: 6.514

Review 4.  'Metabolically healthy obesity': origins and implications.

Authors:  Gerald V Denis; Martin S Obin
Journal:  Mol Aspects Med       Date:  2012-10-13

Review 5.  New tools for weight-loss therapy enable a more robust medical model for obesity treatment: rationale for a complications-centric approach.

Authors:  W Timothy Garvey
Journal:  Endocr Pract       Date:  2013 Sep-Oct       Impact factor: 3.443

Review 6.  Obesity in CKD--what should nephrologists know?

Authors:  Peter Stenvinkel; Carmine Zoccali; T Alp Ikizler
Journal:  J Am Soc Nephrol       Date:  2013-10-10       Impact factor: 10.121

7.  New considerations on hormetic response against oxidative stress.

Authors:  Armando Luna-López; Viridiana Y González-Puertos; Norma E López-Diazguerrero; Mina Königsberg
Journal:  J Cell Commun Signal       Date:  2014-10-05       Impact factor: 5.782

8.  Downregulation of the acetyl-CoA metabolic network in adipose tissue of obese diabetic individuals and recovery after weight loss.

Authors:  Harish Dharuri; Peter A C 't Hoen; Jan B van Klinken; Peter Henneman; Jeroen F J Laros; Mirjam A Lips; Fatiha El Bouazzaoui; Gert-Jan B van Ommen; Ignace Janssen; Bert van Ramshorst; Bert A van Wagensveld; Hanno Pijl; Ko Willems van Dijk; Vanessa van Harmelen
Journal:  Diabetologia       Date:  2014-08-07       Impact factor: 10.122

Review 9.  Studying Adipose Tissue in the Breast Tumor Microenvironment In Vitro: Progress and Opportunities.

Authors:  David Mertz; Jason Sentosa; Gary Luker; Shuichi Takayama
Journal:  Tissue Eng Regen Med       Date:  2020-09-16       Impact factor: 4.169

Review 10.  Metabolic Syndrome in Children and Adolescents: a Critical Approach Considering the Interaction between Pubertal Stage and Insulin Resistance.

Authors:  Thomas Reinehr
Journal:  Curr Diab Rep       Date:  2016-01       Impact factor: 4.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.